# Angiotensin II Receptor Blockers (ARB) and ACE Inhibitors (ACEI) on Silent Brain Infarction and Cognitive Decline

> **NCT00126516** · PHASE4 · COMPLETED · sponsor: **Nara Medical University** · enrollment: 395 (actual)

## Conditions studied

- Brain Infarction
- Hypertension

## Interventions

- **DRUG:** Angiotensin II Receptor Antagonists
- **DRUG:** Angiotensin-converting Enzyme Inhibitors

## Key facts

- **NCT ID:** NCT00126516
- **Lead sponsor:** Nara Medical University
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2004-05
- **Primary completion:** 2013-06
- **Final completion:** 2013-06
- **Target enrollment:** 395 (ACTUAL)
- **Last updated:** 2013-10-30


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00126516

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00126516, "Angiotensin II Receptor Blockers (ARB) and ACE Inhibitors (ACEI) on Silent Brain Infarction and Cognitive Decline". Retrieved via AI Analytics 2026-07-27 from https://api.ai-analytics.org/clinical/NCT00126516. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*